Observational Study of Afatinib 30 mg Daily — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Observational Study of Afatinib 30 mg Daily — Stella

Recruiting

Back to Non-Small Cell Lung Cancer trials

Trial locations(1 site)

Singapore

Nationa University Hospital, Singapore

Key details

Sponsor

National University Hospital, Singapore

Collaborators

Boehringer Ingelheim

Enrollment target

~69 participants

Started

October 2022

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 99 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov